Is There Evidence of Any Safety Differences Among DPP-4 Inhibitors in the Treatment of People with Type 2 Diabetes Mellitus and Reduced GFR Due to Chronic Kidney Disease?

Shranjeno v:
Bibliografske podrobnosti
izdano v:Diabetes Ther
Main Authors: Evans, Marc, Dejager, Sylvie, Schweizer, Anja, Foley, James E.
Format: Artigo
Jezik:Inglês
Izdano: Springer Healthcare 2015
Teme:
Commentary
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4374076/
https://ncbi.nlm.nih.gov/pubmed/25783754
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-015-0104-4
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki